Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Nightly sleep duration, fragmentation, and quality and daily risk of migraine.

Bertisch SM, Li W, Buettner C, Mostofsky E, Rueschman M, Kaplan ER, Fung J, Huntington S, Murphy T, Stead C, Burstein R, Redline S, Mittleman MA.

Neurology. 2020 Feb 4;94(5):e489-e496. doi: 10.1212/WNL.0000000000008740. Epub 2019 Dec 16.

PMID:
31843807
2.

Design and Identification of a Novel, Functionally Subtype Selective GABAA Positive Allosteric Modulator (PF-06372865).

Owen RM, Blakemore D, Cao L, Flanagan N, Fish R, Gibson KR, Gurrell R, Huh CW, Kammonen J, Mortimer-Cassen E, Nickolls SA, Omoto K, Owen D, Pike A, Pryde DC, Reynolds DS, Roeloffs R, Rose C, Stead C, Takeuchi M, Warmus JS, Watson C.

J Med Chem. 2019 Jun 27;62(12):5773-5796. doi: 10.1021/acs.jmedchem.9b00322. Epub 2019 Apr 26.

PMID:
30964988
3.

A Coxiella burnetii phospholipase A homolog pldA is required for optimal growth in macrophages and developmental form lipid remodeling.

Stead CM, Cockrell DC, Beare PA, Miller HE, Heinzen RA.

BMC Microbiol. 2018 Apr 16;18(1):33. doi: 10.1186/s12866-018-1181-0.

4.

Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865.

Nickolls SA, Gurrell R, van Amerongen G, Kammonen J, Cao L, Brown AR, Stead C, Mead A, Watson C, Hsu C, Owen RM, Pike A, Fish RL, Chen L, Qiu R, Morris ED, Feng G, Whitlock M, Gorman D, van Gerven J, Reynolds DS, Dua P, Butt RP.

Br J Pharmacol. 2018 Feb;175(4):708-725. doi: 10.1111/bph.14119. Epub 2018 Jan 18. Erratum in: Br J Pharmacol. 2019 Jan;176(1):127.

5.

Identification of Positive Allosteric Modulators of Glycine Receptors from a High-Throughput Screen Using a Fluorescent Membrane Potential Assay.

Stead C, Brown A, Adams C, Nickolls SJ, Young G, Kammonen J, Pryde D, Cawkill D.

J Biomol Screen. 2016 Dec;21(10):1042-1053. doi: 10.1177/1087057116657779. Epub 2016 Jul 11.

PMID:
27412533
6.

Sec-mediated secretion by Coxiella burnetii.

Stead CM, Omsland A, Beare PA, Sandoz KM, Heinzen RA.

BMC Microbiol. 2013 Oct 5;13:222. doi: 10.1186/1471-2180-13-222.

7.

Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages.

Beare PA, Gilk SD, Larson CL, Hill J, Stead CM, Omsland A, Cockrell DC, Howe D, Voth DE, Heinzen RA.

mBio. 2011 Sep 1;2(4):e00175-11. doi: 10.1128/mBio.00175-11. Print 2011.

8.

Development of reagents and assays for the detection of pathogenic Burkholderia species.

Qazi O, Rani M, Gnanam AJ, Cullen TW, Stead CM, Kensing H, McCaul K, Ngugi S, Prior JL, Lipka A, Nagy JM, Gregory CW, Judy BM, Harding SV, Titball RW, Sidhu SS, Trent MS, Kitto GB, Torres A, Estes DM, Iverson B, Georgiou G, Brown KA.

Faraday Discuss. 2011;149:23-36; discussion 63-77.

9.

Removal of the outer Kdo from Helicobacter pylori lipopolysaccharide and its impact on the bacterial surface.

Stead CM, Zhao J, Raetz CR, Trent MS.

Mol Microbiol. 2010 Nov;78(4):837-52. doi: 10.1111/j.1365-2958.2010.07304.x.

10.

Active-site architecture and catalytic mechanism of the lipid A deacylase LpxR of Salmonella typhimurium.

Rutten L, Mannie JP, Stead CM, Raetz CR, Reynolds CM, Bonvin AM, Tommassen JP, Egmond MR, Trent MS, Gros P.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1960-4. doi: 10.1073/pnas.0813064106. Epub 2009 Jan 27.

11.

Deciphering the unusual acylation pattern of Helicobacter pylori lipid A.

Stead CM, Beasley A, Cotter RJ, Trent MS.

J Bacteriol. 2008 Nov;190(21):7012-21. doi: 10.1128/JB.00667-08. Epub 2008 Aug 29.

12.

Synthesis of and evaluation of lipid A modification by 4-substituted 4-deoxy arabinose analogs as potential inhibitors of bacterial polymyxin resistance.

Kline T, Trent MS, Stead CM, Lee MS, Sousa MC, Felise HB, Nguyen HV, Miller SI.

Bioorg Med Chem Lett. 2008 Feb 15;18(4):1507-10. doi: 10.1016/j.bmcl.2007.12.061. Epub 2007 Dec 27.

13.

Diversity of endotoxin and its impact on pathogenesis.

Trent MS, Stead CM, Tran AX, Hankins JV.

J Endotoxin Res. 2006;12(4):205-23. Review.

PMID:
16953973
14.

The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway.

Ernst RK, Adams KN, Moskowitz SM, Kraig GM, Kawasaki K, Stead CM, Trent MS, Miller SI.

J Bacteriol. 2006 Jan;188(1):191-201.

15.

Resistance to the antimicrobial peptide polymyxin requires myristoylation of Escherichia coli and Salmonella typhimurium lipid A.

Tran AX, Lester ME, Stead CM, Raetz CR, Maskell DJ, McGrath SC, Cotter RJ, Trent MS.

J Biol Chem. 2005 Aug 5;280(31):28186-94. Epub 2005 Jun 10.

16.

Remodeling of Helicobacter pylori lipopolysaccharide.

Tran AX, Stead CM, Trent MS.

J Endotoxin Res. 2005;11(3):161-6.

PMID:
15949144
17.

A novel 3-deoxy-D-manno-octulosonic acid (Kdo) hydrolase that removes the outer Kdo sugar of Helicobacter pylori lipopolysaccharide.

Stead C, Tran A, Ferguson D Jr, McGrath S, Cotter R, Trent S.

J Bacteriol. 2005 May;187(10):3374-83.

18.
19.

Sudden infant death syndrome. 'Preparation is everything'. Interview by Rebecca Coombes.

Stead C.

Nurs Times. 2001 Jul 19-25;97(29):11. No abstract available.

PMID:
11957492
20.

Farewell to A&E.

Stead CE.

Accid Emerg Nurs. 1999 Jul;7(3):175-8.

PMID:
10693389
21.

Efficacy of albendazole against Giardia and hookworm in a remote Aboriginal community in the north of Western Australia.

Reynoldson JA, Behnke JM, Gracey M, Horton RJ, Spargo R, Hopkins RM, Constantine CC, Gilbert F, Stead C, Hobbs RP, Thompson RC.

Acta Trop. 1998 Aug 15;71(1):27-44.

PMID:
9776141
23.
24.

Product inhibition and dose-dependent bioavailability of propranolol in the isolated perfused rat liver preparation.

Ghabrial H, Nand R, Stead CK, Smallwood RA, Morgan DJ.

J Pharm Sci. 1994 Jul;83(7):931-6.

PMID:
7965671
25.

Transfer of acipimox across the isolated perfused human placenta.

Ghabrial H, Czuba MA, Stead CK, Smallwood RA, Morgan DJ.

Placenta. 1991 Nov-Dec;12(6):653-61.

PMID:
1805205
26.

Quinidine single dose pharmacokinetics and pharmacodynamics are unaltered by omeprazole.

Ching MS, Elliott SL, Stead CK, Murdoch RT, Devenish-Meares S, Morgan DJ, Smallwood RA.

Aliment Pharmacol Ther. 1991 Oct;5(5):523-31.

PMID:
1793783
27.

The use of dyes in protein purification.

Stead CV.

Bioseparation. 1991;2(3):129-36. Review.

PMID:
1368080
28.

Subsensitivity to ATP and some analogues in preparations of rat cauda epididymis and vas deferens after vasectomy.

Ventura S, DeGaris RM, Stead CK, Pennefather JN.

Clin Exp Pharmacol Physiol. 1990 Aug;17(8):579-87.

PMID:
2208800
30.

Kinetic assessment of apparent facilitation by albumin of cellular uptake of unbound ligands.

Morgan DJ, Stead CK, Smallwood RA.

J Pharmacokinet Biopharm. 1990 Apr;18(2):121-35.

PMID:
2348379
31.

Novel cationic triazine dyes for protein purification.

Clonis YD, Stead CV, Lowe CR.

Biotechnol Bioeng. 1987 Oct 5;30(5):621-7.

PMID:
18581449
32.

Chronic lameness in dogs.

Campbell J, Stead C.

In Pract. 1983 Jul;5(4):124-33. No abstract available.

PMID:
6885179
33.

1-ethoxy-4-(dichloro-s-triazinyl)naphthalene: a fluorescent reagent for corticosteroids.

Chayen R, Gould S, Harell A, Stead CV.

Anal Biochem. 1971 Feb;39(2):533-5. No abstract available.

PMID:
5555476
34.

A Case of Intussusception in a Patient Aged 72: Laparotomy: Recovery.

Stead CC.

Br Med J. 1901 Nov 16;2(2133):1458-9. No abstract available.

Supplemental Content

Support Center